Biologics is a Sinking Ship - Business Development Manager Curia Employee Review

1.0
14 Mar 2024
Recommend
CEO approval
Business outlook

Pros

Was able to negotiate a competitive base salary.

Cons

In my opinion the LakePharma acquisition was a mistake and management never really understood what they were buying. In September 2021 6 sites and 235 employees joined but 2.5 years later only 2 sites remain open with maybe 75 people. This extreme cost cutting means no investment in innovation or instrumentation and most work is being done by hand. High prices, increasing competition, and a lack of leadership have resulted in an underperforming business. For a 3300+ person company the marketing department is a joke HIGH TURNOVER in all departments = HUGE RED FLAG Private Equity owners = only care about profits and will likely close or sell off more sites this year Talk with some former employees before accepting a job

avatar
Curia Response
2y
Thank you for your review. We take all feedback into consideration when planning for the future and all reviews, like yours, are critical to our ability to implement change. We appreciate you taking the time to share about your experience.

Explore other reviews about Curia

5.0
28 Aug 2024
Recommend
CEO approval
Business outlook

Pros

Great team and great work being done at Curia

Cons

Salary is not high enough I think

5.0
25 Jun 2026
Recommend
CEO approval
Business outlook

Pros

Great team, exciting science, growth opportunities

Cons

Managing growth in difficult economic conditions

See reviews by: Helpful|Rating|Date|All